Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — IVITOC

CIDP Clinical Trial

Official title:
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Status Recruiting

Clinical Trial Summary

This is a randomized controlled study evaluating safety and efficacy of repeated immunoadsorption versus immunoglobulins in steroid-refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

CIDP
Polyneuropathies
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Clinical Trial Details

NCT number	NCT04881682
Study type	Interventional
Source	University of Ulm
Contact	Johannes Dorst, Prof
Phone	+49 731 177 5285
Email	johannes.dorst@uni-ulm.de
Status	Recruiting
Phase	Phase 2
Start date	May 1, 2023
Completion date	March 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05584631` - IVIG vs SCIG in CIDP	Phase 1
Recruiting	`NCT03801135` - Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation	N/A
Active, not recruiting	`NCT01655394` - Change of Nerve Conduction Properties in IVIg Dependent Neuropathies	N/A
Recruiting	`NCT05004493` - Biorepository and Registry for Plasma Exchange Patients
Active, not recruiting	`NCT05723848` - Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Recruiting	`NCT04249752` - Biomarkers in Polyradiculoneuropathies
Recruiting	`NCT05614128` - Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
Completed	`NCT00962429` - Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy	Phase 2
Completed	`NCT02629796` - Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating Polyradiculoneuropathy